New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Students appearing for the NEET-UG Re-Examination 2026 in Odisha will be able to travel…
Bhubaneswar: Bringing Odisha’s festive flavours to the streets of the capital, the Mission Shakti Department…
Bhubaneswar: Efforts to preserve and promote Odisha's vast manuscript heritage received a boost with the…
Bhubaneswar: Odisha's innovative urban governance and water management initiatives have drawn national attention, with a…
New Delhi: In a major step towards unlocking the hydrocarbon potential of the Northeast and…
Bhubaneswar: Students seeking admission to undergraduate courses in Odisha for the 2026–27 academic session have…
